BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14620507)

  • 21. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.
    Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R
    Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours.
    Etrych T; Subr V; Laga R; Ríhová B; Ulbrich K
    Eur J Pharm Sci; 2014 Jul; 58():1-12. PubMed ID: 24632485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymer therapeutics with a coiled coil motif targeted against murine bcl1 leukemia.
    Pola R; Laga R; Ulbrich K; Sieglová I; Král V; Fábry M; Kabešová M; Kovář M; Pechar M
    Biomacromolecules; 2013 Mar; 14(3):881-9. PubMed ID: 23373696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers.
    Wang D; Kopecková JP; Minko T; Nanayakkara V; Kopecek J
    Biomacromolecules; 2000; 1(3):313-9. PubMed ID: 11710118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
    Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K
    J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
    Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
    J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
    Arabi L; Badiee A; Mosaffa F; Jaafari MR
    J Control Release; 2015 Dec; 220(Pt A):275-286. PubMed ID: 26518722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour tropism and anti-cancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanoma.
    Seymour LW; Ulbrich K; Steyger PS; Brereton M; Subr V; Strohalm J; Duncan R
    Br J Cancer; 1994 Oct; 70(4):636-41. PubMed ID: 7917909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel star HPMA-based polymer conjugates for passive targeting to solid tumors.
    Etrych T; Strohalm J; Chytil P; Říhová B; Ulbrich K
    J Drug Target; 2011 Dec; 19(10):874-89. PubMed ID: 21978286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates.
    Shiah JG; Sun Y; Kopecková P; Peterson CM; Straight RC; Kopecek J
    J Control Release; 2001 Jul; 74(1-3):249-53. PubMed ID: 11489502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates.
    Luo Y; Bernshaw NJ; Lu ZR; Kopecek J; Prestwich GD
    Pharm Res; 2002 Apr; 19(4):396-402. PubMed ID: 12033370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
    Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K
    Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPMA copolymer-doxorubicin-gadolinium conjugates: synthesis, characterization, and in vitro evaluation.
    Zarabi B; Nan A; Zhuo J; Gullapalli R; Ghandehari H
    Macromol Biosci; 2008 Aug; 8(8):741-8. PubMed ID: 18484565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes.
    Ríhová B; Etrych T; Pechar M; Jelínková M; Stastný M; Hovorka O; Kovár M; Ulbrich K
    J Control Release; 2001 Jul; 74(1-3):225-32. PubMed ID: 11489498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release.
    Chytil P; Šírová M; Kudláčová J; Říhová B; Ulbrich K; Etrych T
    Mol Pharm; 2018 Sep; 15(9):3654-3663. PubMed ID: 29543465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy.
    Kostková H; Etrych T; Ríhová B; Kostka L; Starovoytová L; Kovář M; Ulbrich K
    Macromol Biosci; 2013 Dec; 13(12):1648-60. PubMed ID: 24031022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
    J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.
    Trail PA; Willner D; Knipe J; Henderson AJ; Lasch SJ; Zoeckler ME; TrailSmith MD; Doyle TW; King HD; Casazza AM; Braslawsky GR; Brown J; Hofstead SJ; Greenfield RS; Firestone RA; Mosure K; Kadow KF; Yang MB; Hellström KE; Hellström I
    Cancer Res; 1997 Jan; 57(1):100-5. PubMed ID: 8988048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors.
    Koziolová E; Janoušková O; Cuchalová L; Hvězdová Z; Hraběta J; Eckschlager T; Sivák L; Ulbrich K; Etrych T; Šubr V
    J Control Release; 2016 Jul; 233():136-46. PubMed ID: 27189135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.